CIK 0001335105 · Non-accelerated filer<br>Smaller reporting company
NOMAD POWER SOLUTIONS, INC.
Sign in to watch- Ticker
- NMAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202903526
- Phone
- 310 203 2902
- Business address
- 433 PLAZA REAL, SUITE 275, BOCA RATON, FL, 33432
- Former names
- LIXTE BIOTECHNOLOGY HOLDINGS, INC., SRKP 7 INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 3 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-24 | Primus Guy Warren Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-12-24 | Felix Lourdes Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-09-01 | Stazzone Peter Chief Financial Officer | Grant or award · Options to Purchase Common Stock | +50,000 | 50,000 | ||
| 2025-08-15 | Sawyer Jason David Director | Grant or award · Options to Purchase Common Stock | +25,000 | 25,000 | ||
| 2025-08-15 | Holloway Michael Andrew Director | Grant or award · Options to Purchase Common Stock | +25,000 | 25,000 | ||
| 2025-07-03 | Pursglove Geordan Garrett CEO and Chairman of the Board | Grant or award · Options to Purchase Common Stock | +350,000 | 350,000 | ||
| 2025-06-30 | Yen Yun Director | Grant or award · Options to Purchase Common Stock | +10,000 | 10,000 | ||
| 2025-06-30 | Yen Yun Director | Grant or award · Options to Purchase Common Stock | +11,632 | 11,632 | ||
| 2025-06-30 | Forman Stephen J. Director | Grant or award · Options to Purchase Common Stock | +10,000 | 10,000 | ||
| 2025-06-30 | Forman Stephen J. Director | Grant or award · Options to Purchase Common Stock | +7,754 | 7,754 | ||
| 2025-06-30 | Bernards Rene Director | Grant or award · Options to Purchase Common Stock | +10,000 | 10,000 | ||
| 2025-06-30 | Bernards Rene Director | Grant or award · Options to Purchase Common Stock | +10,662 | 10,662 | ||
| 2025-06-30 | Brown Regina Director | Grant or award · Options to Purchase Common Stock | +10,000 | 10,000 | ||
| 2025-06-30 | Brown Regina Director | Grant or award · Options to Purchase Common Stock | +12,600 | 12,600 | ||
| 2025-03-31 | Yen Yun Director | Grant or award · Options to Purchase Common Stock | +8,777 | 8,777 | ||
| 2025-03-31 | Bernards Rene Director | Grant or award · Options to Purchase Common Stock | +8,045 | 8,045 | ||
| 2025-03-31 | Forman Stephen J. Director | Grant or award · Options to Purchase Common Stock | +5,851 | 5,851 | ||
| 2025-03-31 | Brown Regina Director | Grant or award · Options to Purchase Common Stock | +9,508 | 9,508 | ||
| 2025-01-20 | Forman Stephen J. Director | Grant or award · Options to Purchase Common Stock | +3,030 | 3,030 | ||
| 2025-01-20 | Yen Yun Director | Grant or award · Options to Purchase Common Stock | +4,545 | 4,545 |
Page 2 of 8 · 145 trades